SCHEMBL31225342

SCHEMBL31225342

CC[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.51
▸ HINT1 P49773 4/20 0.51
▸ HPGD P15428 2/20 0.51
▸ ADORA3 P0DMS8 1/20 0.50
▸ NT5E P21589 1/20 0.47
▸ ADA P00813 1/20 0.45
▸ PNP P00491 1/20 0.44
▸ GSK3A P49840 2/20 0.44
▸ RPS6KA3 P51812 2/20 0.44
▸ MAPK14 Q16539 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ STING1 Q86WV6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18636462 1.00 ADORA2A (0.51) ADORA2AHINT1HPGDADORA3NT5E
SCHEMBL19352193 0.90 ADORA3 (0.50) ADORA2AHINT1HPGDADORA3NT5E
SCHEMBL14594720 0.90 ADORA3 (0.50) ADORA2AHINT1HPGDADORA3NT5E
SCHEMBL20250995 0.90 ADORA2A (0.53) ADORA2AHINT1HPGDADORA3NT5E
SCHEMBL6429463 0.89 HPGD (0.49) ADORA2AHINT1HPGDADORA3NT5E
2'-B-Methyl-Guanosine SCHEMBL10819905 0.89 ADORA2A (0.65) ADORA2AHINT1HPGDADORA3NT5E
2'-B-Methyl-Guanosine SCHEMBL14842089 0.89 ADORA2A (0.65) ADORA2AHINT1HPGDADORA3NT5E
2'-B-Methyl-Guanosine SCHEMBL10208618 0.89 ADORA2A (0.65) ADORA2AHINT1HPGDADORA3NT5E
2'-B-Methyl-Guanosine SCHEMBL12758165 0.89 ADORA2A (0.65) ADORA2AHINT1HPGDADORA3NT5E
2'-B-Methyl-Guanosine SCHEMBL21007207 0.89 ADORA2A (0.65) ADORA2AHINT1HPGDADORA3NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024183748-A1 LOCKED NUCLEOSIDE CAP ANALOGUE AND USE 江苏申基生物科技有限公司 2024-09-12 — — WO disclosed
Send feedback